Get started
Work

Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade

Year: 2018
Type: article
Source: Nature
DOI: 10.1038/s41586-018-0768-9
Authors: Jeffrey J. Ishizuka, Robert T. Manguso, Collins K. Cheruiyot, Kevin Bi, Arpit Panda, Arvin Iracheta-Vellve, Brian C. Miller, Peter P. Du, Kathleen B. Yates, Juan Dubrot, Ilana Buchumenski, Dawn E. Comstock, Flavian D. Brown, Austin Ayer, Ian C. Kohnle, Hans W. Pope, Margaret D. Zimmer, Debattama R. Sen, Sarah K. Lane-Reticker, Emily J. Robitschek, Gabriel K. Griffin, Natalie B. Collins, Adrienne H. Long, John G. Doench, David Kozono, Erez Y. Levanon, W. Nicholas Haining
Institutions: Broad Institute, Dana-Farber Cancer Institute, Massachusetts Institute of Technology, Harvard University, Bar-Ilan University, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber/Harvard Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W2904139947
FWCI: 22.13
Cites: 39
Cited by: 683
Related to: 10